Page 85 - Development Command News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Development command. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Development Command Today - Breaking & Trending Today

GSDF staffer not prosecuted over alleged molestation of school girl


GSDF staffer not prosecuted over alleged molestation of school girl
By Tokyo Reporter Staff on February 5, 2021
TOKYO (TR) – Prosecutors have announced the non-prosecution of a 35-year-old Ground Self-Defense Force member over the alleged molestation of an elementary school girl last month, reports NHK (Feb. 4).
At around 2:00 p.m. on January 11, Takuya Kubo, a major in the Ground Research and Development Command, allegedly abducted the girl, a fifth-year student, from an event in Chiyoda Ward.
Kubo then took the girl into a room of a building in neighboring Chuo Ward and fondled her body.
The following day, police arrested Kubo for abduction for the purpose of obscenity and indecent assault. Police did not reveal whether he admitted to the allegations. ....

Takuya Kubo , Tokyo District Public Prosecutor Office , Ground Research , Ground Self Defense Force , Development Command , Chuo Ward , Tokyo District Public Prosecutor , Chuo Police Station , டோக்கியோ மாவட்டம் பொது ப்ராஸெக்யூடர் அலுவலகம் , தரையில் ஆராய்ச்சி , தரையில் சுய பாதுகாப்பு படை , வளர்ச்சி கட்டளை , சுோ வார்டு , டோக்கியோ மாவட்டம் பொது ப்ராஸெக்யூடர் , சுோ போலீஸ் நிலையம் ,

Hoth Therapeutics Provides Operational Update on Novel Therapeutic Pipeline


Hoth Therapeutics Provides Operational Update on Novel Therapeutic Pipeline
News provided by
Share this article
Share this article
NEW YORK, Feb. 2, 2021 /PRNewswire/ Hoth Therapeutics, Inc. (NASDAQ: HOTH), a biopharmaceutical company today is providing shareholders with an update on its pipeline of novel therapeutics targeting dermatological, COVID-19 and support care indications.
Drug Pipeline Highlights:
HT-001: Granted Pre-IND meeting with FDA with responses targeted for February 22, 2021
HT-003: Received positive preclinical mechanism of action date for acne treatment and renewal of the preclinical research plan
HT-004: Key proof-of-concept animal model data expected in Q2 2021
Mr. Robb Knie, Chief Executive Officer of Hoth, commented,  Hoth s entire pipeline of innovative novel therapeutics have made significant progress throughout their developmental process over the course of the last year.  During that time, we have been able ....

Charles River , United States , Halovax Vaxcelerate , Robb Knie , Walter Reed Army Institute Of Research , Voltron Therapeutics Inc , Human Research Ethics Committee , Virginia Commonwealth University , Drug Administration , Lr Advisors , Hoth Therapeutics Inc , Army Medical Research , Exchange Commission , Therapeutics Inc , Development Command , Prnewswire Hoth Therapeutics Inc , Immunotherapy Center At Massachusetts , Pipeline Highlights , Lexa Platform , Chief Executive Officer , Charles River Laboratories , Cutaneous Lupus Erythematosus , Walter Reed Army Institute , Massachusetts General Hospital , Voltron Therapeutics , Hoth Therapeutics ,

Qventus Closes 2020 with Premier Partnerships and New Automation Solutions


Press release content from PR Newswire. The AP news staff was not involved in its creation.
Qventus Closes 2020 with Premier Partnerships and New Automation Solutions
February 1, 2021 GMT
(PRNewsfoto/Qventus)
MOUNTAIN VIEW, Calif., Feb. 1, 2021 /PRNewswire/ Qventus, the first real-time operations system for healthcare, today announced that it had achieved significant milestones for 2020 as it helped health system and hospital partners address near-term Covid-19 capacity challenges and unlock long-term operational efficiencies. From launching and expanding a range of partnerships with health systems across the country to introducing a series of innovative new solutions, Qventus made significant advances toward unlocking step-change increases in efficiency by enabling real-time health systems. ....

United States , Prnewswire Qventus , Mudit Garg , Commonspirit Health , Boston Medical Center , National Emergency Response Telecritical Care Network , Technology Research Center , Saint Luke Health System , Us Army Medical Research , M Health Fairview , Robert Wood Johnson Foundation , Marshfield Clinic Health System , Unitypoint Health , Minnesota Critical Care Command Center , Critical Resource Mission , Development Command , University Of Arkansas , Saint Luke , Health System , Medical Research , Advanced Technology Research Center , Qventus Inpatient Solution , Inpatient Solution , Improvement Automation , Strategic Partner , Scenario Planner ,

Wearables in Healthcare | Medical Grade Wearables


What You Should Know: - Best Buy Health, today announced it is offering a full array of health and safety services available on the Apple Watch to help to make it easier for older adults to stay safe, healthy, and connected. - Now Apple Watch users with the Lively app can get help from highly trained Lively Urgent Response Agents to get help in an emergency and non-emergency situations, from medical emergencies to car trouble and more. How to Access Lively Health & Safety Services ....

United States , Zimmer Biomet , Fred Pennic , Jasmine Pennic , Akhil Saklecha , University Of California , Us Army Medical Research , Anthem Inc , European Union , Northwell Health Feinstein Institutes For Medical Research , Worldwide Developers Conference , Development Command , Medical Grade , Should Know , Medical Research , Northwell Health , Feinstein Institutes , Cleveland Clinic , Will Morris , Cleveland Clinic Innovations , Apple Watch , ஒன்றுபட்டது மாநிலங்களில் , ஸிம்மர் பயோமெட் , பல்கலைக்கழகம் ஆஃப் கலிஃபோர்னியா , எங்களுக்கு இராணுவம் மருத்துவ ஆராய்ச்சி , கீதம் இன்க் ,

Regulus Announces Addition to Board of Directors


Regulus Announces Addition to Board of Directors
News provided by
Share this article
LA JOLLA, Calif., Jan. 27, 2021 /PRNewswire/
 Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRNAs, today announced Alice S. Huang, Ph.D. has been appointed to the Company s board of directors. Concurrently with her appointment to the Board, Dr. Huang was appointed to serve on the Compensation Committee.
We are pleased to add Dr. Huang to the Regulus board.  We believe her extensive scientific background will be of benefit to helping direct the Company s drug discovery and development programs, said Stelios Papadopoulos, Ph.D., Chairman of the Board of Directors of Regulus.  ....

United States , University Of Massachusetts , Stelios Papadopoulos , Alices Huang , Johns Hopkins University , National Foundation For Infectious Diseases , National Cancer Institute , Health Effects Institute , Compensation Committee , American Association For The Advancement Of Science , American Academy Of Microbiology , Food Drug Administration , Us Army Medical Research Development , Schlesinger Library At Radcliffe Institute , Regulus Therapeutics Inc , American Association Of Women , California Institute Of Technology , Molecular Genetics At Harvard Medical School , Rockefeller Foundation , Professor Of Biology At New York University , Regulus Therapeutics , Senior Faculty Associate , Biological Engineering , California Institute , New York University , Molecular Genetics ,